Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to focus on safety of Novartis gene therapy drug
FDA panel to focus on safety of Novartis gene therapy drug
FDA panel to focus on safety of Novartis gene therapy drug
Submitted by
admin
on July 10, 2017 - 9:32am
Source:
Yahoo/Reuters
News Tags:
FDA
advisory panels
Novartis
gene therapy
CAR-T
acute lymphoblastic leukemia
Headline:
FDA panel to focus on safety of Novartis gene therapy drug
Do Not Allow Advertisers to Use My Personal information
